Clinical Implications of Opioid Pharmacogenomics in Patients With Cancer.
about
A Novel Sensitive Method to Measure Catechol-O-Methyltransferase Activity Unravels the Presence of This Activity in Extracellular Vesicles Released by Rat Hepatocytes.Prospective replication study implicates the catechol-O-methyltransferase Val158Met polymorphism as a biomarker for the response to morphine in patients with cancer.The pharmacogenetics of medications used in general anesthesia.CYP2D6 pharmacogenetic and oxycodone pharmacokinetic association study in pediatric surgical patients.
P2860
Clinical Implications of Opioid Pharmacogenomics in Patients With Cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Clinical Implications of Opioid Pharmacogenomics in Patients With Cancer.
@en
type
label
Clinical Implications of Opioid Pharmacogenomics in Patients With Cancer.
@en
prefLabel
Clinical Implications of Opioid Pharmacogenomics in Patients With Cancer.
@en
P2093
P2860
P1433
P1476
Clinical Implications of Opioid Pharmacogenomics in Patients With Cancer.
@en
P2093
Gillian C Bell
Howard L McLeod
Kristine A Donovan
P2860
P304
P356
10.1177/107327481502200408
P577
2015-10-01T00:00:00Z